Watch for Ketoacidosis With Flozins
See updated FDA information (December 2015) concerning SGLT2 inhibitors (Flozins) and ketoacidosis/urinary tract infections.
Colleagues will ask you whether Invokana (canagliflozin) and other SGLT2 inhibitors or "flozins" are linked to ketoacidosis.This seems to be a flozin class effect...and has researchers scratching their heads about the mechanism.
It's different from the ketoacidosis we typically see with VERY high blood glucose. It's happening in patients with type 1 or 2 diabetes when glucose levels are near normal or only slightly elevated.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote